Search Results for "Gardex Embolic Protection"
Original Source: GORE Embolic Protection With Reverse Flow
To compare the 30-day safety and efficacy of the GORE Flow Reversal System when used with approved carotid stents to an Objective Performance Criterion derived from distal embolic protection studies.
Matching Channels
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals,...
India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps...
Generics Drugs - news, views, reports
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration,...
Subacute cutaneous lupus erythematosus SCLE
Subacute cutaneous lupus erythematosus (SCLE) is a nonscarring non–atrophy-producing photosensitive dermatosis. SCLE may occur in patients with systemic lupus erythematosus (SLE), Sjögren...
Sphingosine-1-phospate (S1P) is a phospholipid released by platelets, mast and other cells. It is now known that S1P stimulates at least five different G-protein coupled receptors (GPCRs): S1P1, S1P2,...
Matching News
InspireMD to commence MGuard embolic protection stent study
InspireMD has received approval for its investigational device exemption (IDE) application from the US Food and Drug Administration (FDA) to initiate MASTER II clinical study of its MGuard embolic pr...
Japan approves first embolic beads for HCC
An early 2009 Japanese government request for the development of embolic microbead therapies for the treatment of serious cancers has finally been answered more than four years later with the approval...
Co-founder and CEO of InspireMD to step down
Ofir Paz is retiring as CEO of InspireMD, which is gearing up for the commercial release of its MGuard Embolic Protection Ste -More-
Claret Medical, Inc. Announces CE Mark Approval of Montage 2™ and Live Case Debut During JIM 2013
SANTA ROSA, Calif., Feb. 27, 2013 /PRNewswire/ -- Claret Medical, Inc. announced today that its 2nd generation filtration system, Montage 2 Dual Filter System received CE Mark approval with an in...
TCT: Stent with Mesh Cover Helps in Acute MI (CME/CE)
MIAMI (MedPage Today) -- When restoring blood flow in acute MI, a stent covered in mesh for embolic protection appears to resolve ischemia better than conventional stents, researchers found.
MGuard stent shows positive result in MASTER trial
InspireMD's Mguard embolic protection stent has demonstrated a positive outcome in treating patients suffering heart attacks when compared to bare metal or drug-eluting stents during the study.
CardioLogical Solutions, an emerging cardiovascular device company formed by the recent merger of Emboline and VasoStitch, announced today that it has been issued an additional pa...
FOPO nets $23.3mm for [InspireMD]
Cardiovascular device firm [InspireMD Inc.] has netted $23.3mm through the follow-on public offering of 12.5mm common shares at $2. The company will use the funds to retire its convertible debentures,...
Matching PubMed Articles
Aims: We describe the first-in-human experience with a novel cerebral embolic protection device used during transcatheter aortic valve implantation (TAVI). One current challenge of TAVI is the reducti...
Carotid Stenting and Transcranial Doppler Monitoring: Indications for Carotid Stenosis Treatment.
Background: Recently, angioplasty and stenting of carotid arteries (CAS) have taken the place of surgery. The aim of our study is to assess the role of transcranial Doppler (TCD) monitoring during CAS...
The multicenter PROTECT AF study (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) was conducted to determine whether percutaneous left atrial appenda...
Final Results of the Protected Superficial Femoral Artery Trial Using the FilterWire EZ System.
The purpose of this study was to evaluate the safety and efficacy of debris-capture for distal protection using the FilterWire EZ Embolic Protection System (Boston Scientific, Mountain View, CA) with...
Aims: To report our first-in-man experience with a new cerebral embolic deflection device (SMT Embolic Deflection Device) during transcatheter aortic valve implantation (TAVI). A significant number of...
